Bioextrax AB (publ) (STO:BIOEX)
Sweden
· Delayed Price · Currency is SEK 2.730
-0.010 (-0.36%)
Mar 9, 2026, 5:13 PM CET
Bioextrax AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3.93 | 17.27 | 13.4 | 27.53 | 8.98 | Upgrade
|
| Cash & Short-Term Investments | 3.93 | 17.27 | 13.4 | 27.53 | 8.98 | Upgrade
|
| Cash Growth | -77.23% | 28.87% | -51.33% | 206.69% | 337.54% | Upgrade
|
| Accounts Receivable | 0.03 | - | - | 0.03 | 0.12 | Upgrade
|
| Other Receivables | 0.53 | 0.73 | 0.71 | 1.27 | 0.79 | Upgrade
|
| Receivables | 0.56 | 0.73 | 0.71 | 1.3 | 0.91 | Upgrade
|
| Prepaid Expenses | 1.06 | 0.29 | 0.29 | 0.34 | 0.22 | Upgrade
|
| Other Current Assets | - | 0.91 | 0.36 | 1.23 | 1.31 | Upgrade
|
| Total Current Assets | 5.54 | 19.2 | 14.76 | 30.4 | 11.42 | Upgrade
|
| Property, Plant & Equipment | 5.84 | 6.82 | 7.76 | 7.49 | 1.22 | Upgrade
|
| Other Long-Term Assets | 13.34 | 2.98 | - | 0.03 | - | Upgrade
|
| Total Assets | 24.73 | 29 | 22.52 | 37.92 | 12.64 | Upgrade
|
| Accounts Payable | 1.18 | 1.53 | 1.33 | 3.56 | 2.22 | Upgrade
|
| Accrued Expenses | 1.6 | 0.84 | 0.44 | 0.98 | 1.04 | Upgrade
|
| Current Income Taxes Payable | 0.08 | 0.1 | 0.14 | 0.13 | 0.06 | Upgrade
|
| Current Unearned Revenue | - | - | -0.59 | 0.89 | 1.41 | Upgrade
|
| Other Current Liabilities | 0.66 | 0.47 | 0.67 | 0.6 | 0.41 | Upgrade
|
| Total Current Liabilities | 3.51 | 2.94 | 1.98 | 6.15 | 5.14 | Upgrade
|
| Total Liabilities | 3.51 | 2.94 | 1.98 | 6.15 | 5.14 | Upgrade
|
| Common Stock | 2.02 | 1.97 | 1.47 | 1.28 | 0.74 | Upgrade
|
| Additional Paid-In Capital | 12.14 | 22.32 | 9.86 | 41.73 | 15.96 | Upgrade
|
| Retained Earnings | 6.68 | 1.73 | 9.21 | -11.24 | -9.2 | Upgrade
|
| Comprehensive Income & Other | 0.38 | 0.05 | - | - | 0 | Upgrade
|
| Shareholders' Equity | 21.22 | 26.06 | 20.54 | 31.77 | 7.5 | Upgrade
|
| Total Liabilities & Equity | 24.73 | 29 | 22.52 | 37.92 | 12.64 | Upgrade
|
| Net Cash (Debt) | 3.93 | 17.27 | 13.4 | 27.53 | 8.98 | Upgrade
|
| Net Cash Growth | -77.23% | 28.87% | -51.33% | 206.69% | 337.54% | Upgrade
|
| Net Cash Per Share | 0.10 | 0.52 | 0.51 | 1.63 | 0.67 | Upgrade
|
| Filing Date Shares Outstanding | 40.03 | 39.12 | 29.23 | 25.46 | 14.75 | Upgrade
|
| Total Common Shares Outstanding | 40.03 | 39.12 | 29.23 | 25.46 | 14.75 | Upgrade
|
| Working Capital | 2.03 | 16.26 | 12.78 | 24.25 | 6.28 | Upgrade
|
| Book Value Per Share | 0.53 | 0.67 | 0.70 | 1.25 | 0.51 | Upgrade
|
| Tangible Book Value | 21.22 | 26.06 | 20.54 | 31.77 | 7.5 | Upgrade
|
| Tangible Book Value Per Share | 0.53 | 0.67 | 0.70 | 1.25 | 0.51 | Upgrade
|
| Machinery | - | 9.99 | 9.77 | 8.64 | 1.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.